Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

AbbVie (NY: ABBV )

173.70 +2.35 (+1.37%)
Official Closing Price Updated: 4:10 PM EST, Jan 16, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about AbbVie

< Previous 1 2
...
30 31 32 33 34 35 36 37 38
...
72 73 Next >
GlycoMimetics: A Breakthrough In Hematopoietic Stem Cell Transplantation
Blood cancers such as AML, MM, and MDS affect a terrible toll on patients and their loved ones. Glycomimetics may be such a company that can offer patients suffering from various blood cancers hope... 
Via Talk Markets
Check Out 3 Health Care Stocks With Over 3% Dividend Yields From Wall Street's Most Accurate Analysts
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high... 
Via Benzinga
7 Dividend Stocks That Will Pay You Through Any Market Turmoil
With market conditions looking rather worrying, anxious investors turn to the best dividend stocks for market crash list. 
Via InvestorPlace
Looking At AbbVie's Recent Unusual Options Activity
Via Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Here's How Much $1000 Invested In AbbVie 10 Years Ago Would Be Worth Today
Via Benzinga
2 Things About AbbVie That Investors Are Ignoring
AbbVie shares slipped following the latest earnings report. 
Via The Motley Fool
Check Out What Whales Are Doing With ABBV
Via Benzinga
Where Will AbbVie Be in 5 Years?
AbbVie has been a strong performer since its split from Abbott Labs, and it's trying hard to keep the momentum going. 
Via The Motley Fool
1 Relatively Safe Dividend Growth Stock to Buy Hand Over Fist Right Now
Look past the bad news, at how this company will perform in the future. 
Via The Motley Fool
Looking for Steady, Passive Income? Buy AbbVie Stock
The drugmaker looks poised to rebound from its Humira loss of exclusivity. 
Via The Motley Fool
3 Great Income Stocks That Retirees Should Love
If you're looking for additional retirement income, these three stocks should be right up your alley. 
Via The Motley Fool
7 Dividend-Paying Large-Cap Stocks to Buy in May
Here are some of the best dividend-paying large-cap stocks available that provide stability and income. 
Via InvestorPlace
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
7 Stock Upgrades and Downgrades Alerts You Cannot Ignore
Analyst stock upgrades and downgrades caught the market's attention in the last week and putting investors on notice for buys and sells. 
Via InvestorPlace
AbbVie Stock Plunged: Should You Buy the Dip?
Last week's sell-off appears to have been overdone. 
Via The Motley Fool
AbbVie's Blockbuster Is Falling Fast. Time to Sell?
Rapidly declining Humira sales weren't the only disappointment AbbVie shared in its first-quarter earnings report. 
Via The Motley Fool
Vertex Pharmaceuticals Just Lost a Potential Rival. Is the Stock a Buy?
Vertex dominates the cystic fibrosis market today. 
Via The Motley Fool
High-Yield Pfizer Falls Off The COVID Cliff, And Survives
Pfizer is a value and high-yield compared to its peers and it it outperforming expectations in 2023; The pipeline is robust. 
Via MarketBeat
Topics Intellectual Property
Exposures COVID-19 Intellectual Property
3 of the Best High-Yielding Dividend Stocks to Buy in May
These dividend stocks are trading at cheap prices, and long-term investors should consider buying them right now. 
Via The Motley Fool
Vertex Pharmaceuticals Stock Is an Even Better Buy Now Thanks to AbbVie
One big drugmaker's pain translates into another big drugmaker's gain. 
Via The Motley Fool
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
AbbVie (ABBV) Q1 2023 Earnings Call Transcript
ABBV earnings call for the period ending March 31, 2023. 
Via The Motley Fool
Why AbbVie Stock Is Crashing Today
AbbVie's 2023 Q1 report isn't sitting well with shareholders today. 
Via The Motley Fool
Are These 3 Elite Dividend Stocks a Buy After Q1 Earnings?
These highly prized dividend stocks no longer come across as table-pounding buys. 
Via The Motley Fool
7 High-Yield Dividend Stocks to Buy and Hold Forever
A stagnant market can be frustrating, but also a good time to look for high-yield dividend stocks to buy now. 
Via InvestorPlace
3 Unstoppable Stocks to Buy Right Now
Don't let the temporary headwinds for two of these stocks fool you. 
Via The Motley Fool
Market Rally Wobbles Amid Big Earnings Moves From Microsoft, Meta, Crocs, Cloudflare: Weekly Review
Microsoft, Meta, Cloudflare and Crocs were among the many big movers. 
Via Investor's Business Daily
How AI Is Revolutionizing Tech, and Why You Should Invest in These Leading Companies
Check out these compelling opportunities. 
Via The Motley Fool
Could Government Drug-Price Negotiations Sound The Death Knell For Biotech Stocks?
Experts fear a change in how Medicare buys drugs could slam biotech and pharma companies. 
Via Investor's Business Daily
< Previous 1 2
...
30 31 32 33 34 35 36 37 38
...
72 73 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.